Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Feldtkeller E, Khan M, Heijde D van der, Linden S van der, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003;23(2):61-6.
2. Rudwaleit M, Listing J, Brandt J, Braun J. Prediction of a major clinical response (BASDAI50) to tumour necrosis factor alfa blockers in ankylosing spondylitis. Ann Rheum Dis 2004;63:665-70.
3. Malleson P, Petty R. Clinical and therapeutic aspects of juvenile-onset spondyloarthropathies. Curr Opin Rheumatol 1997;9:291-4.
4. Maksymowitch W, Chou C, Russell A. Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis. Ann Rheum Dis 1995;54:128.
5. Mielants H, Veys E, Vos M de, Cuvelier C, Goemaere S, Clercq L de, et al. The evolution of spondylarthropathies in relation to gut histology I. Clinical aspects. J Rheumatol 1995;22:2266-72.